Protect Pharmaceutical Corporation
PRTT · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 2.6% | -13.7% | -3% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 55.7% | 56.1% | 53.9% | 71.5% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 33.6% | 34.1% | 34.5% | 71.3% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 25.2% | 25.6% | 33.8% | 85.1% |
| EPS Diluted | 0.12 | 0.11 | 0.18 | 0.45 |
| % Growth | 9.1% | -38.9% | -60% | – |
| Operating Cash Flow | -$0 | $0 | $0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | $0 |
| Free Cash Flow | -$0 | $0 | $0 | -$0 |